Participant flow

S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery · Source last updated 2018-01-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. id

   FG000

   title

   AZD2171 (Cediranib Maleate)

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         6

      type

      Ineligible

   2. reasons

      1. group Id

         FG000

         num Subjects

         6

      type

      Adverse Event

   3. reasons

      1. group Id

         FG000

         num Subjects

         2

      type

      Withdrawal by Subject

   4. reasons

      1. group Id

         FG000

         num Subjects

         36

      type

      Lack of Efficacy

   5. reasons

      1. group Id

         FG000

         num Subjects

         2

      type

      Death

   6. reasons

      1. group Id

         FG000

         num Subjects

         1

      type

      not protocol specified

   7. reasons

      1. group Id

         FG000

         num Subjects

         1

      type

      Did not receive any treatment

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         54

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         0

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         54

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice